Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.1.01877
European Journal of Endocrinology, Vol 152, Issue 4, 557-567
Copyright © 2005 by Society of the European Journal of Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kendall-Taylor, P.
Right arrow Articles by Verhelst, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kendall-Taylor, P.
Right arrow Articles by Verhelst, J.

CLINICAL STUDY

The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma

Pat Kendall-Taylor, Peter J Jönsson1, Roger Abs2, Eva Marie Erfurth3, Maria Koltowska-Häggström1, David Anthony Price4 and Johan Verhelst5

University of Newcastle, Newcastle upon Tyne, UK, 1 KIGS/KIMS Outcomes Research, Pharmacia, Stockholm, Sweden, 2 Antwerp Metabolic Research Unit, University of Antwerp, Belgium, 3 University Hospital, Lund, Sweden, 4 Royal Manchester Children’s Hospital, Manchester, UK and 5 Middelheim Hospital, Antwerp, Belgium

(Correspondence should be addressed to P Kendall-Taylor, SCMS, Floor 4, Leech Building, Medical School, Newcastle upon Tyne NE2 4HH, UK; Email: pat.kendall-taylor{at}newcastle.ac.uk)

Background: Craniopharyngioma is a parasellar tumour that, although benign, tends to behave aggressively. It can occur at any age but most commonly presents in childhood or adolescence.

Objectives: To investigate the frequency and severity of problems associated with craniopharyngioma, using the large international database (KIMS) for adult patients with GH deficiency (GHD), and to assess the differences between the adult onset (AO, aged 18 or above) disease and adults with childhood onset (CO) craniopharyngioma.

Design: Inclusion criteria were: an established diagnosis of craniopharyngioma, severe GHD and no recent GH treatment. These criteria were fulfilled by 393 (184 female, 209 male) patients; 241 had AO (mean age 28.7±8.7 years) and 152 had CO disease (age 42.0±12.3 years). Disease history, clinical features and anthropometric data were recorded at the time of enrolment in the database, and body composition, serum IGF-I, serum lipids and quality of life (QoL) were assessed.

Results: Peak age at onset of craniopharyngioma was 15–20 years. Ninety percent of patients had been treated surgically. CO patients were shorter than AO patients and had much lower IGF-I standard deviation scores (SDS). The majority had hypopituitarism and over 60% had diabetes insipidus. Body mass index (BMI) was higher in AO males (30.2±5.5) than in CO males (28.5±7.5); waist circumference was also greater. Obesity was more common in AO patients (51.8% vs 39.1%). Body composition did not differ between groups. Cholesterol and triglycerides were higher in AO than in CO patients, but high density lipoprotein (HDL)- and low density lipoprotein (LDL)-cholesterol did not differ. Quality of life, assessed by Quality of Life-Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA) and the Nottingham Health Profile, was markedly reduced in all groups with no significant differences between them; the QoL-AGHDA score correlated with age at onset of both craniopharyngioma and GHD, and also with BMI in AO patients.

Conclusions: These data emphasise the generally poor state of health of patients treated for craniopharyngioma, with respect to endocrine and metabolic function, and also the markedly reduced quality of life. In addition to GHD, most patients have evidence of hypothalamic damage with associated obesity, diabetes insipidus and hypopituitarism. Adults with CO craniopharyngioma were shorter, had lower IGF-I, lower BMI, less obesity and slightly lower blood lipid levels than patients with AO craniopharyngioma.




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
K. Stochholm, T. Laursen, A. Green, P. Laurberg, M. Andersen, L. O. Kristensen, U. Feldt-Rasmussen, J. S. Christiansen, M. Frydenberg, and C. H. Gravholt
Morbidity and GH deficiency: a nationwide study.
Eur. J. Endocrinol., April 1, 2008; 158(4): 447 - 457.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
C. Hoybye, P. Jonsson, J. P Monson, M. Koltowska-Haggstrom, V. Hana, M. Geffner, and R. Abs
Impact of the primary aetiology upon the clinical outcome of adults with childhood-onset GH deficiency
Eur. J. Endocrinol., November 1, 2007; 157(5): 589 - 596.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
H. Urushihara, S. Fukuhara, S. Tai, S. Morita, and K. Chihara
Heterogeneity in responsiveness of perceived quality of life to body composition changes between adult- and childhood-onset Japanese hypopituitary adults with GH deficiency during GH replacement
Eur. J. Endocrinol., June 1, 2007; 156(6): 637 - 645.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
O M Dekkers, N R Biermasz, J W A Smit, L E Groot, F Roelfsema, J A Romijn, and A M Pereira
Quality of life in treated adult craniopharyngioma patients.
Eur. J. Endocrinol., March 1, 2006; 154(3): 483 - 489.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Society of the European Journal of Endocrinology.